hypertension News
Most Popular hypertension Story
Safety concerns force delay for Phase III ED trial
With regulators at the FDA waving a red flag over safety concerns, King Pharmaceuticals and Palatin Technologies announced that they will delay the planned launch of a Phase III trial of... Read more...
Latest Headlines
- May 30, 2008
- May 23, 2008
- May 16, 2008
- April 7, 2008
- March 20, 2008
- February 5, 2008
- December 18, 2007
- November 7, 2007
- August 30, 2007
- January 28, 2007
- December 12, 2006
- November 29, 2006
- October 1, 2006
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
